BNP Paribas Financial Markets’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $27 | Hold |
|
|||||
|
2025
Q1 | $30 | Hold |
|
|||||
|
2024
Q4 | $54 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $123 | Hold |
|
|||||
|
2024
Q1 | $206 | Hold |
|
|||||
|
2023
Q4 | $99 | Hold |
|
|||||
|
2023
Q3 | $73 | Hold |
|
|||||
|
2023
Q2 | $750 | Hold |
|
|||||
|
2023
Q1 | $1.2K | Hold |
|
|||||
|
2022
Q4 | $597 | Hold |
|
|||||
|
2022
Q3 | $1.61K | Hold |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $1.62K | Hold |
|
|||||
|
2021
Q4 | $1.92K | Hold |
|
|||||
|
2021
Q3 | $1.59K | Sell |
|
|||||
|
2021
Q2 | $7.23K | Sell |
|
|||||
|
2021
Q1 | $15.6K | Sell |
|
|||||
|
2020
Q4 | $27.7K | Sell |
|
|||||
|
2020
Q3 | $113K | Buy |
|
|||||
|
2020
Q2 | $11.2K | Buy |
|